Hhlr Advisors, Ltd. Codiak Bio Sciences, Inc. Transaction History

Hhlr Advisors, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.0 - $16.78 $1.43 Million - $2.4 Million	-142,978 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.58 - $22.88 $3.49 Million - $5.12 Million	-223,743 Reduced 61.01%	142,978 $2.34 Million
Q4 2020 Feb 12, 2021	BUY	$7.9 - $32.3 $2.9 Million - $11.8 Million	366,721 New	366,721 $11.8 Million

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.